BYF inhibited the inflammation of COPD by the way of suppressing the phosphorylation of STAT3 and promoting phosphorylation of STAT5 to promote the differentiation of Tregs but inhibit the differentiation of Th17 cells. Here, STAT3 is linked to chronic obstructive pulmonary disease.